Risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

dc.creatorO'Ryan Gallardo, Miguel
dc.creatorPrado Jiménez, Valeria
dc.date.accessioned2019-01-29T14:12:14Z
dc.date.available2019-01-29T14:12:14Z
dc.date.created2019-01-29T14:12:14Z
dc.date.issued2000
dc.identifierNew England Journal of Medicine, Volumen 343, Issue 17, oct 16, 2000, pages 1271-1271
dc.identifier00284793
dc.identifier10.1056/NEJM200010263431716
dc.identifierhttps://repositorio.uchile.cl/handle/2250/160144
dc.languageen
dc.publisherMassachusetts Medical Society
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceNew England Journal of Medicine
dc.subjectHemolytic–Uremic Syndrome
dc.subjectEscherichia coliO157:H7
dc.titleRisk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución